Medios AG | Finanzwire

BRIEF

published on 08/05/2024 at 10:37, 1 year 7 months ago

Medios Expands Advanced Therapies and Appoints Dr. Andreas Schmiede as VP

Medios AG Advanced Therapies Personalized Medicine Specialty Pharma Dr. Andreas Schmiede
PRESS RELEASE

published on 08/05/2024 at 10:32, 1 year 7 months ago

Medios expands „Advanced Therapies“ field and appoints Dr. Andreas Schmiede as Vice President
Medios AG strengthens activities in Advanced Therapies field, appoints Dr. Andreas Schmiede as Vice President. Focus on personalized medicine innovations and patient access to cutting-edge therapies

Medios AG Advanced Therapies Personalized Medicine Dr. Andreas Schmiede Pharmaceutical Innovations
BRIEF

published on 07/01/2024 at 09:37, 1 year 8 months ago

“Hauptstadtkongress 2024”: Medios Hosts Symposium on 'Security of Supply'

Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
PRESS RELEASE

published on 07/01/2024 at 09:32, 1 year 8 months ago

“Hauptstadtkongress 2024”: Medios hosts symposium on 'Security of supply”
Medios AG participated in 'Hauptstadtkongress 2024', focusing on 'Security of supply'. Experts discussed challenges in patient care and the importance of cooperation in Specialty Pharma sector

Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
BRIEF

published on 06/20/2024 at 10:07, 1 year 9 months ago

Successful Transfer of Medios AG Shares to Luxempart S.A.

Investment Medios AG Share Sale Specialty Pharma Luxempart S.A.
PRESS RELEASE

published on 06/20/2024 at 10:02, 1 year 9 months ago

Medios AG: Successful sale of shares from Company founder Manfred Schneider to Luxempart S.A.
Medios AG founder Manfred Schneider sells 14.9% of shares to Luxempart S.A., a Luxembourg investment company, marking a turning point in Medios' growth strategy

Investment Medios AG Specialty Pharma Luxempart S.A. Manfred Schneider
BRIEF

published on 06/07/2024 at 10:33, 1 year 9 months ago

Hauck & Aufhäuser Initiates Coverage of Medios AG with Buy Recommendation and €23.00 Price Target

Buy Recommendation Medios AG Specialty Pharma Hauck & Aufhäuser Price Target €23.00
PRESS RELEASE

published on 06/07/2024 at 10:28, 1 year 9 months ago

Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00
Hauck & Aufhäuser initiates coverage of Medios AG with buy recommendation and €23.00 price target, a 55% upside potential from Xetra closing price on June 5, 2024. Medios AG, a leading Specialty Pharma provider in Europe, aims at expanding innovative therapies

Buy Recommendation Medios AG Price Target Specialty Pharma Hauck & Aufhäuser
BRIEF

published on 06/06/2024 at 11:37, 1 year 9 months ago

Medios AG Completes Acquisition of Ceban, Expanding Market Position in Europe

Acquisition European Market Medios AG Ceban Pharmaceuticals Specialty Pharma
PRESS RELEASE

published on 06/06/2024 at 11:32, 1 year 9 months ago

Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe
Medios AG completes acquisition of Ceban, expanding market position in Europe. Ceban, a pharmaceutical compounding platform, adds strategic diversification and growth opportunities

Acquisition Medios AG Pharmaceutical Compounding Ceban Pharmaceuticals B.V. European Market Position

Published on 03/26/2026 at 14:05, 2 hours 17 minutes ago

SouthGobi Announces Profit Warning
Published on 03/26/2026 at 13:00, 3 hours 22 minutes ago

Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 3 hours 22 minutes ago

GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 3 hours 23 minutes ago

Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 3 hours 37 minutes ago

Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia

View all ACCESSWIRE

Published on 03/26/2026 at 15:25, 57 minutes ago

Duck Creek Loss Control Named 2026 Insurance Luminary Finalist by PropertyCasualty360
Published on 03/26/2026 at 15:23, 59 minutes ago

Sartorius AG - Resolutions of the Annual General Meeting
Published on 03/26/2026 at 15:05, 1 hour 17 minutes ago

JOY GROUP Announces 2025 Financial Results, Revenue Surpasses US$620M
Published on 03/26/2026 at 15:01, 1 hour 21 minutes ago

EQS-Adhoc: CENIT AG decides to switch from the Regulated Market (Prime Standard) to the Scale Segment of the Frankfurt Stock Exchange
Published on 03/26/2026 at 15:00, 1 hour 22 minutes ago

OLB’s financial performance remains at a consistently high level

View all EQS

Published on 03/26/2026 at 08:57, 7 hours 25 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 8 hours 52 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:53, 21 hours 29 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 21 hours 51 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 22 hours 37 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting

View all LES ECHOS COMFI WIRE

News